Despite mixed phase 3 showing, Apellis hopes to push eye disorder drug past FDA’s finish line

Despite mixed phase 3 showing, Apellis hopes to push eye disorder drug past FDA’s finish line
nhigginsdunn
Thu, 09/09/2021 – 15:34